Rosuvastatin, Inflammation, C-Reactive Protein, JUPITER, and Primary Prevention of Cardiovascular Disease &Ndash; A Perspective

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s10812
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

To JUPITER and Beyond: Statins, Inflammation, and Primary Prevention

Critical Care
Critical CareIntensive Care Medicine
2010English

C-Reactive Protein and Cardiovascular Disease in East Asians: A Systematic Review

Clinical Medicine Insights: Cardiology
Cardiovascular MedicineCardiology
2014English

The Use of High Sensitivity C-Reactive Protein in Cardiovascular Disease Detection

Journal of Pharmacy and Pharmaceutical Sciences
MedicinePharmacologyPharmaceutical Science
2018English

Statins for Primary Prevention of Cardiovascular Disease

British Medical Journal
Medicine
2019English

Fiber's Impact on High-Sensitivity C-Reactive Protein Levels in Cardiovascular Disease

Journal of the American Academy of Nurse Practitioners
2010English

Comparative Study of C Reactive Protein and Serum Amyloid a Protein in Experimental Inflammation.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1991English

Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein

New England Journal of Medicine
Medicine
2008English

C-Reactive Protein and Coronary Artery Disease

Japanese Heart Journal
2002English

C-Reactive Protein as a Predictor of Cardiovascular Events in Elderly Patients With Chronic Kidney Disease

Journal of Nephrology
Nephrology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy